Search filters

List of works by Daniel Kuritzkes

"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication

scientific article published on 04 January 2020

A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?

scientific article

A Plea for Justice for Jailed Medical Workers

scientific article published in Science

A comparison of three initial antiretroviral AIDS regimens

scientific article published on 01 September 2007

A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128.

scientific article

A packaged intervention to improve viral load monitoring within a deeply rural health district of South Africa

scientific article published on 11 November 2020

A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors

scientific article

A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.

scientific article published on January 2007

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein

scientific article

Accuracy of the TRUGENE HIV-1 genotyping kit.

scientific article

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).

scientific article published on 24 May 2005

Acute On‐Chip HIV Detection Through Label‐Free Electrical Sensing of Viral Nano‐Lysate ⬇️

scientific article published on February 27, 2013

Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions

scientific article

Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy

scientific article published on 2 October 2015

Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors

scientific article

Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy

scientific article

Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).

scientific article published on January 2006

An update on HIV-1 antiretroviral resistance

scientific article published on September 2006

Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy ⬇️

scientific article published on August 15, 2011

Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers

scientific article published on 01 April 2020

Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.

scientific article published on 8 January 2004

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

scientific article published on July 2008

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

scientific article published on August 2008

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

scientific article published in May 2000

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

scientific article published on 23 June 2003

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

scientific article

Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary

scientific article published on December 2007

Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases

scientific article

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection

scientific article published on 7 June 2005

Assessing Resistance Costs of Antiretroviral Therapies via Measures of Future Drug Options ⬇️

scientific article published on September 23, 2003

Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions

scientific article published on 3 June 2009

Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Workin

scientific article published in October 1996

Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy ⬇️

scientific article published on April 18, 2013

Baseline CD4+ T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients ⬇️

scientific article published on January 1, 2011

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency

scientific article

Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials

scientific article published on 20 February 2016

CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy

scientific article published on 28 October 2015

Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.

scientific article

Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals

scientific article

Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team.

scientific article published in January 2000

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial ⬇️

scientific article published on March 30, 2012

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points

scientific article published in April 1999

Chemokine antagonists as therapeutics: focus on HIV-1.

scientific article published on January 2007

Clinical Implications of HIV-1 Minority Variants ⬇️

scientific article published on February 27, 2013

Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases

scientific article published on 01 March 1999

Clinically validated genotype analysis: guiding principles and statistical concerns.

scientific article published in August 2004

Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children

scientific article published on 2 August 2002

Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa

scientific article

Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation

scientific article

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens

scientific article published on September 2000

Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy

scientific article

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase

scientific article

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257

scientific article

Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals

scientific article published in November 2004

Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370.

scientific article published on September 2002

Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial

scientific article published on 01 September 2000

Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease

scientific article published on December 2006

Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.

scientific article

Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa

scientific article published on 9 December 2013

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.

scientific article published on 6 July 2017

Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group

scientific article published on 01 February 1997

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

scientific article

Current management challenges in HIV: antiretroviral resistance

scientific article published on March 1, 2003

Cytotoxic T Lymphocyte Lines Specific for Human Immunodeficiency Virus Type 1 Gag and Reverse Transcriptase Derived from a Vertically Infected Child ⬇️

scientific article published on March 1, 1993

DNA engineered micromotors powered by metal nanoparticles for motion based cellphone diagnostics

scientific article published in Nature Communications

Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.

scientific article published on February 2009

Design issues in initial HIV-treatment trials: focus on ACTG A5095.

scientific article published in January 2006

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets

scientific article published in January 2010

Development of a microfluidic system for measuring HIV-1 viral load

scientific article

Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa

scientific article published on 11 September 2008

Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists ⬇️

scientific article published on January 17, 2012

Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics

scientific article

Drug Resistance Mutations in HIV-1

scientific article published on 01 November 2002

Drug development strategies for salvage therapy: conflicts and solutions

scientific article published in November 2006

Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options

scientific article

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

scientific article

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

scientific article

Drug resistance mutations in HIV-1.

scientific article published on November 2003

Drug resistance mutations in HIV-1.

scientific article

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

scientific article

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

scientific article

EFFECT OF SHORT-TERM ART INTERRUPTION ON LEVELS OF INTEGRATED HIV DNA.

scientific article published on 28 March 2018

Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).

scientific article

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile

scientific article published on 01 November 2019

Early intensification with abacavir in subjects at high risk for incomplete viral suppression

scientific article published on August 1, 2003

Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic

scientific article published on December 2013

Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts

scientific article published in April 2008

Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness

scientific article

Effect of the Q207D mutation in HIV type 1 reverse transcriptase on zidovudine susceptibility and replicative fitness

scientific article published in September 2005

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team

scientific article published in February 2000

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial

scientific article published on October 2014

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) ⬇️

scientific article published on November 13, 2011

Efficient on-chip isolation of HIV subtypes ⬇️

scientific article published on March 6, 2012

Elevated Levels of Microbial Translocation Markers and CCL2 Among Older HIV-1-Infected Men

scientific article published on 22 October 2015

Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy

scientific article published in January 2000

Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia

scientific article published on March 2011

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

scientific article

Emerging technologies for point-of-care management of HIV infection.

scientific article

Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin

scientific article published on January 2008

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

scientific article (publication date: 29 May 2003)

Enumeration of CD4+ T-cells using a portable microchip count platform in Tanzanian HIV-infected patients

scientific article

Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.

scientific article published on 3 September 2012

Episomal Viral cDNAs Identify a Reservoir That Fuels Viral Rebound after Treatment Interruption and That Contributes to Treatment Failure ⬇️

scientific article published on February 24, 2011

Evaluation of HIV-1 Ambiguous Nucleotide Frequency During Antiretroviral Treatment Interruption ⬇️

scientific article published on September 1, 2012

Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate

scientific article

Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial ⬇️

scientific article published on April 1, 2011

Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.

scientific article

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study

scientific article

Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures

scientific article published on 01 March 1999

Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation

scientific article published on 17 June 2017

HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States

scientific article published on 16 March 2016

HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life

scientific article published on 13 April 2020

HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication

scientific article published in July 1999

HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians

scientific article

HIV resistance: frequency, testing, mechanisms.

scientific article

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

scientific article published on 17 January 2007

HIV viral load markers in clinical practice

scientific article published on June 1996

HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug ⬇️

scientific article published on November 16, 2011

HIV-1 entry inhibitors: an overview

scientific article

HIV-1 entry inhibitors: recent development and clinical use ⬇️

scientific article published on January 3, 2013

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

scientific article published on 7 November 2017

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

scientific article published on January 2007

HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers

scientific article published on 20 August 2018

HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course

scientific article published on 01 December 2003

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection

scientific article

High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998-2004.

scientific article published in October 2007

High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen

scientific article published on August 2012

High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay

scientific article

Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol.

scientific article published on June 1999

Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial

scientific article

Hiv Controllers Maintain Viral Suppression Despite Waning T-Cell Responses On Art

scientific article published on 04 June 2020

Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation

scientific article

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy

scientific article

Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping

scientific article published on May 1, 1992

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants

scientific article published on 05 May 2016

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response

scientific article published on 01 January 2000

Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen

scientific article published on 13 November 2003

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315 ⬇️

scientific article published on July 1, 1998

Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor

scientific article published on 01 August 2019

Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response

scientific article published on 29 April 2004

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption

scientific article published on 27 November 2017

Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure

scientific article published on 21 December 2012

In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1.

scientific article published in September 1996

In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children ⬇️

scientific article published on July 1, 1998

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

scientific article

In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject

scientific article published on 21 May 2008

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.

scientific article

In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine

scientific article

Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia

scientific article

Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.

scientific article published on 22 February 2018

Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mL ⬇️

scientific article published on November 15, 2012

Increased replication of HIV-1 minor variants during hematopoietic stem-cell mobilization with filgrastim

scientific article published on 22 June 2004

Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells

scientific article published on 01 July 1999

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

scientific article

Infection of the retina by human immunodeficiency virus type I.

scientific article published in December 1987

Inhibition of Human Immunodeficiency Virus Type 1 Replication In Vitro by the Bisheteroarylpiperzine Atevirdine (U-87201E) in Combination with Zidovudine or Didanosine ⬇️

scientific article published on August 1, 1993

Inhibition of Purified Recombinant Reverse Transcriptase from Wild‐Type and Zidovudine‐Resistant Clinical Isolates of Human Immunodeficiency Virus Type 1 by Zidovudine, Stavudine, and Lamivudine Triphosphates ⬇️

scientific article published on October 15, 2001

Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response

scientific article published in August 2008

Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy

scientific article

Integrating microfluidics and lensless imaging for point-of-care testing

scientific article

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression

scientific article published on April 2007

Interaction of Reverse Transcriptase (RT) Mutations Conferring Resistance to Lamivudine and Etravirine: Effects on Fitness and RT Activity of Human Immunodeficiency Virus Type 1 ⬇️

scientific article published on August 17, 2011

Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group

scientific article published on July 1996

Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group.

scientific article

International AIDS Society global scientific strategy: towards an HIV cure 2016.

scientific article published on 11 July 2016

Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen

scientific article

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.

scientific article

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

article

Lensless imaging for point-of-care testing.

scientific article

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy

scientific article

Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation

scientific article published on 4 March 2013

Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa

scientific article published on July 2010

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

scientific article published in April 2011

Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR ⬇️

scientific article published on September 4, 2012

Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.

scientific article published on March 2009

MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study

scientific article published in November 2003

Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)

scientific article published on 01 April 2007

Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care

scientific article

Mobile Health (mHealth) Viral Diagnostics Enabled with Adaptive Adversarial Learning

scientific article published on 23 November 2020

Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance

scientific article published in July 2005

Monitoring HIV treatment in developing countries

scientific article

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team

scientific article published on 01 June 1997

Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen

scientific article

Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana

scientific article published on 16 March 2020

Motion-Based Immunological Detection of Zika Virus Using Pt-Nanomotors and a Cellphone.

scientific article published on 16 May 2018

Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy

scientific article

Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.

scientific article

NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation

article

Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood

scientific article

Nanostructured optical photonic crystal biosensor for HIV viral load measurement

scientific article

Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients

scientific article published on 13 September 2002

Outcomes after virologic failure of first-line ART in South Africa

scientific article

Paper and flexible substrates as materials for biosensing platforms to detect multiple biotargets

scientific article

Paper microchip with a graphene-modified silver nano-composite electrode for electrical sensing of microbial pathogens.

scientific article published on 15 November 2016

Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366

scientific article published on 01 April 2020

Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression

scientific article

Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine

scientific article published in March 2000

Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System

scientific article

Performance of Human Immunodeficiency Virus Type 1 gp41 Assays for Detecting Enfuvirtide (T-20) Resistance Mutations.

scientific article published in November 2006

Performance of human immunodeficiency virus type 1 gp41 assays for detecting enfuvirtide (T-20) resistance mutations

scientific article published on September 2006

Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen

scientific article published in June 2005

Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation

scientific article published in December 2004

Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence

scientific article published in April 2006

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study

scientific article published on 27 December 2005

Pharmacogenomics of HIV Therapy: Summary of a Workshop Sponsored by the National Institute of Allergy and Infectious Diseases ⬇️

scientific article published on September 1, 2011

Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211).

scientific article

Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team

scientific article published on 01 August 1996

Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211

scientific article published on 05 June 2007

Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine

scientific article

Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia

scientific article

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group

scientific article

Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s

scientific article published on 06 March 2007

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy

scientific article

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

scientific article

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects

scientific article published in March 2008

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia ⬇️

scientific article published on August 13, 2012

Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana

scientific article

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

scientific article

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

scientific article published on May 2008

Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion

scientific article

Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva

scientific article published on 5 June 2015

Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.

scientific article published in October 1996

Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV.

scientific article published on 6 October 2017

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

scientific article

Quantum dot-based HIV capture and imaging in a microfluidic channel

scientific article

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel

scientific article published in July 2003

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.

scientific article

Rapid automated cell quantification on HIV microfluidic devices

scientific article

Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis

scientific article published on 01 September 2006

Rapid expansion of access to antiretroviral therapy (ART)

scientific article published on 01 June 2004

Rapid, label-free CD4 testing using a smartphone compatible device

scientific article

Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens

scientific article published in May 2004

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV

scientific article

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting

scientific article published on 15 March 2019

Relationship between Human Immunodeficiency Virus Type 1 (HIV‐1)–Specific Memory Cytotoxic T Lymphocytes and Virus Load after Recent HIV‐1 Seroconversion ⬇️

scientific article published on November 13, 2001

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

scientific article

Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study

scientific article

Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20).

scientific article published on May 2004

Reply

scientific article published on 01 August 1999

Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy

scientific article published on June 2013

Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure

scientific article published in November 1998

Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211

scientific article

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

Role of Baseline pol Genotype in HIV-1 Fitness Evolution

scientific article

SARS-CoV-2 viral load is associated with increased disease severity and mortality

scientific article published on 30 October 2020

SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses

scientific article (publication date: 2011)

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life

scientific article published on 12 January 2020

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection ⬇️

scientific article

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

scientific article

Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults

scientific article

Second-line antiretroviral therapy: long-term outcomes in South Africa

scientific article published on October 2012

Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy

scientific article published in October 1999

Simple filter microchip for rapid separation of plasma and viruses from whole blood ⬇️

scientific article published on September 17, 2012

Small differences in CD4+ T-cell production may go unnoticed

scientific article published on 01 February 1999

Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates.

scientific article published on September 1994

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

scientific article

Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095

scientific article

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

scientific article published in October 2014

Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations

scientific article

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

scientific article published on August 2007

Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in Botswana.

scientific article published in May 2018

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

scientific article published on 01 November 2018

The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates

scientific article

The ethical case for placebo control in HIV-cure-related studies with ART interruption

scientific article published in 2022

The future of HIV treatment

scientific article

The impact of the President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and why it remains essential

scientific article

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

scientific article

The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

scientific article published on 19 November 2015

Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248 ⬇️

scientific article published on June 24, 2013

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial

scientific article published on August 2006

Three-Year Safety and Efficacy of Vicriviroc, a CCR5 Antagonist, in HIV-1–Infected Treatment-Experienced Patients ⬇️

scientific article published on August 1, 2010

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy

scientific article published in January 2000

Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.

scientific article

Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing

scientific article published on 23 January 2016

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.

scientific article

Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration.

scientific article published on 5 July 2017

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

scientific article published on 01 December 1995

Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load

scientific article

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

scientific article published on April 2004

Tropism testing in the clinical management of HIV-1 infection

scientific article

Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.

scientific article published on 22 February 2018

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

scientific article published on 9 October 2000

Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment

scientific article published on January 2009

Update of the Drug Resistance Mutations in HIV-1.

scientific article published on December 2008

Update of the Drug Resistance Mutations in HIV-1: 2005.

scientific article

Update of the drug resistance mutations in HIV-1: 2004.

scientific article

Update of the drug resistance mutations in HIV-1: 2007.

scientific article published on August 2007

Update of the drug resistance mutations in HIV-1: December 2009.

scientific article

Update of the drug resistance mutations in HIV-1: December 2010.

scientific article published on December 2010

Update of the drug resistance mutations in HIV-1: Fall 2005.

scientific article published in October 2005

Update of the drug resistance mutations in HIV-1: Fall 2006.

scientific article published in August 2006

Update of the drug resistance mutations in HIV-1: Spring 2008

scientific article published on 01 April 2008

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines

scientific article published on 05 February 2020

Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures ⬇️

scientific article published on April 4, 2012

Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide

scientific article published on August 2008

Viral kinetics: implications for treatment.

scientific article

Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32

scientific article published on May 2015

Virologic Response, Early HIV-1 Decay, and Maraviroc Pharmacokinetics With the Nucleos(t)ide-Free Regimen of MaravIroc Plus Darunavir/Ritonavir in a Pilot Study ⬇️

scientific article published on October 1, 2013

Virologic and regimen termination surrogate end points in AIDS clinical trials

scientific article published in February 2001

Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase

scientific article published on August 2007

Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa

scientific article

What risk of death would people take to be cured of HIV and why? A survey of people living with HIV

scientific article published on 01 April 2019

World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countries ⬇️

scientific article published on November 1, 2003

Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions

scientific article

Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group

scientific article published on 01 March 1995

Paulina is supported by:

About Paulina

Help